New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›iShares›IUHE
IUHE

iShares S&P 500 Health Care Sector UCITS ETF

Dist
EUR
Hedged
Passive ETFEquity
Not rated

The IUHE Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: S&P 500 Capped 35/20 Health Care Index. The IUHE ETF provides physical exposure, so by buying it you actually own parts of all the 61 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

€8.34
-€0.18 (-2.14%) 2 days ago
8:00 AM 11/06/26 Closed
1D price range
€8.21€8.36
52W price range
€6.46€8.69
YTD Perf.
+19.11%
YTD Flows
Annualized volatility
Fund AuM
€3.34B
Share class AuM
€134M
TTM Yield
Tracking Error
Tracking Difference
ISIN
IE00BMBKBZ46
TER
0.18%
Inception date
6/12/2020
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Nov 6, 2026
-10%-5%0%5%10%15%20%25%JANMARMAYJULSEPNOV
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
98.10%
Consumer Non-Cyclicals
1.79%
Unavailable
0.11%
Latest IUHE news

No content available for this fund

FAQ about IUHE

IUHE is a passively managed ETF that invests in the US Health Care segment.
IUHE tracks the S&P 500 Capped 35/20 Health Care NTR Index - USD, through a full replication replication method.
IUHE carries a total expense ratio (TER) of 0.18%.
IUHE was introduced to the market on June 12, 2020.
iShares S&P 500 Health Care Sector UCITS ETF, IUHE, is provided by iShares. Learn more about iShares here.
Yes, IUHE is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .
IUHE oversees €134M in assets as of November 6, 2026.
IUHE follows a distributing dividend policy, meaning it pays out income to investors. As of November 6, 2026, its 12-month trailing yield was 1.09%.
As of September 30, 2026, IUHE has significant geographic allocations in USA and Ireland.
As of September 30, 2026, IUHE focuses largely on Healthcare and Consumer Non-Cyclicals.
As of September 30, 2026, IUHE holds 61 positions in its portfolio, with 71.41% of assets concentrated in its top 15 holdings.
As of September 30, 2026, IUHE top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of IUHE is EUR.
IUHE is hedged, meaning it seeks to minimize the impact of currency fluctuations between its base currency and the currency of the underlying assets.
Data as of 09/30/26
Eli Lilly & Co.
15.15%
Johnson & Johnson
10.44%
AbbVie, Inc.
7.57%
Merck & Co., Inc.
5.87%
UnitedHealth Group, Inc.
5.40%
Thermo Fisher Scientific, Inc.
4.09%
Amgen, Inc.
3.73%
Gilead Sciences, Inc.
3.03%
Abbott Laboratories
2.80%
Pfizer Inc.
2.66%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight